Emergency coronary angioplasty in patients with severe left ventricular dysfunction or cardiogenic shock after acute...

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Myocardial Infarction Management

Background:

• Acute myocardial infarction (AMI) with severe left ventricular dysfunction or cardiogenic shock presents a critical challenge.
• Thrombolytic therapy is a primary treatment, but success rates vary, especially in complex cases.

Purpose of the Study:

• To evaluate the efficacy of emergency percutaneous transluminal coronary angioplasty (PTCA) in patients with AMI experiencing severe left ventricular dysfunction or cardiogenic shock.
• To assess the impact of PTCA on coronary artery patency, left ventricular function, and hemodynamic parameters.

Main Methods:

• Retrospective analysis of 37 patients undergoing PTCA during AMI over 13 months.
• Six patients with severe left ventricular dysfunction or cardiogenic shock received emergency PTCA after initial thrombolytic therapy.
• Coronary angiography, mechanical guidewire techniques, and balloon angioplasty were employed.

Main Results:

• PTCA successfully reduced mean diameter stenosis from 98.8% to 27% (P < 0.005).
• Left ventricular ejection fraction significantly improved from 27% to 41% (P < 0.02).
• Hemodynamic improvements included increased blood pressure (86 to 126 mmHg, P < 0.005) and cardiac index (2.2 to 3.3 L/min/m², P < 0.01), with decreased left ventricular end-diastolic pressure (26 to 18 mmHg, P < 0.05).

Conclusions:

• Emergency PTCA is a viable and effective treatment for selected AMI patients with severe left ventricular dysfunction or cardiogenic shock.
• PTCA significantly improves myocardial perfusion, ventricular function, and hemodynamic stability in this high-risk patient group.
• Mechanical revascularization via PTCA offers a crucial therapeutic option when initial thrombolysis is insufficient.